These results robustly support the possibility that ctHBx is more oncogenic than HBx through the inhibition of tumor-suppressive β-catenin/BAMBI signaling, which seems to be derived from a C-terminal truncation of HBx (Figure 5g). Here, BAMBI is linked to neoplasm.